Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

DeepSnap: From Three-Dimensional Molecular Images to Quantitative Structure-Activity Predictions.

International journal of molecular sciences·2026
Same author

Chemical Motifs Associated with FAERS-Derived Severe Cutaneous Adverse Reaction Disproportionality Signals: An Interpretable Pharmacovigilance-Driven Cheminformatics Study.

International journal of molecular sciences·2026
Same author

Disproportionality Analysis and Timing of Drug-Associated Guillain-Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Tumor-specific cytotoxicity of pyrazole-based chalcone derivatives in human oral squamous cell carcinoma cell lines.

Turkish journal of biology = Turk biyoloji dergisi·2025
Same author

A Comprehensive Analysis of Adverse Events Associated with HER2 Inhibitors Approved for Breast Cancer Using the FDA Adverse Event Report System (FAERS).

Pharmaceuticals (Basel, Switzerland)·2025

相关实验视频

Updated: Jan 13, 2026

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
03:57

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

2.3K

类固醇诱导的血栓形成:使用FAERS数据库进行全面分析.

Ayame Watanabe1, Yoshihiro Uesawa1

  • 1Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.

Pharmaceuticals (Basel, Switzerland)
|October 29, 2025
PubMed
概括

类固醇药物,特别是性激素,增加了血栓形成的风险,包括静脉血栓形成和大血管封闭. 了解这些风险有助于为高风险患者选择更安全的类固醇药物.

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 血栓形成研究研究
  • 药品安全 药品安全

背景情况:

  • 类固醇药物可以诱导血栓形成,这是一种具有严重后果的疾病,如心脏病发作和中风.
  • 目前对类固醇诱导的血栓形成机制和不同风险的知识有限.

研究的目的:

  • 调查各种类固醇药物类与血栓形成风险之间的关系.
  • 为了确定特定的类固醇类型,更容易引起血栓事件.

主要方法:

  • 使用美国食品和药物管理局的不良事件报告系统 (2004-2024年).
  • 提取的人口,药物和不良事件数据.
  • 通过生理功能,受体特异性和解剖治疗化学品分类来表征类固醇.

主要成果:

  • 性激素 (雄激素,孕激素,雌激素) 显示出发生血栓事件的高潜力.
  • 通过统计分析,性激素制剂与静脉血栓形成风险增加有关.
  • 心血管药物和矿物质皮质类药物与大血管封闭有关.

结论:

  • 这些发现突出了与明显的血栓形成风险相关的特定类型的类固醇药物.
关键词:
在FAERS数据库中,我们可以找到FAERS数据库.动脉血栓形成 动脉血栓形成药物监督和药物监督性激素 性激素 性激素类固醇类固醇是什么静脉血栓塞栓症是一种静脉血栓塞栓.

更多相关视频

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.8K

相关实验视频

Last Updated: Jan 13, 2026

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis
03:57

Ferric Chloride-Induced Arterial Thrombosis and Sample Collection for 3D Electron Microscopy Analysis

Published on: March 17, 2023

2.3K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.8K
  • 这些信息可以指导临床决策,在脆弱患者中选择更安全的类固醇疗法.